Phio Pharmaceuticals Corp. (PHIO)
NASDAQ·Healthcare·Biotechnology
$1.04
+2.97%
Mkt Cap $13.08M
No analyst coverage available
We don't have analyst ratings or price target data for Phio Pharmaceuticals Corp. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.